VLDL receptor
The VLDL receptor (VLDLR) is a protein that in humans is encoded by the VLDLR gene. It is a member of the low-density lipoprotein receptor (LDLR) family, which plays a crucial role in the metabolism of lipoproteins and the regulation of lipid homeostasis.
Structure[edit]
The VLDL receptor is structurally similar to other members of the LDL receptor family. It consists of several domains, including ligand-binding repeats, an epidermal growth factor (EGF) precursor homology domain, and a cytoplasmic domain. These structural features are important for its function in binding and internalizing lipoproteins.

Function[edit]
The primary function of the VLDL receptor is to mediate the endocytosis of very low-density lipoproteins (VLDL) and intermediate-density lipoproteins (IDL). It is involved in the transport and metabolism of triglyceride-rich lipoproteins. The receptor is expressed in various tissues, including the heart, muscle, and adipose tissue, where it facilitates the uptake of lipoproteins for energy production and storage.
Role in Disease[edit]
The VLDL receptor has been implicated in several diseases, particularly those related to lipid metabolism. Mutations or dysregulation of the VLDLR can lead to disorders such as hyperlipidemia and atherosclerosis. Additionally, the receptor has been studied in the context of cerebral malaria, where it is thought to play a protective role.

Developmental Role[edit]
In addition to its role in lipid metabolism, the VLDL receptor is involved in the development of the central nervous system. It interacts with Reelin, a protein that regulates neuronal migration and positioning during brain development. This interaction is crucial for proper corticogenesis, the process by which the cerebral cortex is formed.

Related Pages[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian